Medtronic AF Luxembourg SARL, part of Medtronic Plc, is a Luxembourgish company that functions as an investment holding company.

SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such as heart failure, arrhythmia, and renal failure.

Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension. Its technology involves endovascular catheters to provide an efficacious, durable, cost-effective, and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.

Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA.

Medtronic Ardian LLC, a subsidiary of Medtronic Plc, is a company headquartered in the United States that provides medical technology services.

Suzhou Rainmed Medical Technology Co., Ltd. is a company headquartered in Nano, China, with subsidiaries in that country. The firm develops surgical robotic equipment. It was founded in 2014. Yong Hui Lyu and Yun Fei Huo are the current co-CEOs of the company.

Mercator MedSystems’ mission is to become a global leader in interventional, site-specific delivery of therapeutics that improve patient outcomes in vascular disease, oncology, and regenerative medicine. The 15th and 16th Centuries marked the beginning of the Age of Exploration, a time of bold action, vast territorial expansion and profound intellectual discovery. Gerardus Mercator (1512-1594), a mathematician and cartographer, played a key role in these ventures. He was as important to navigation as Copernicus was to astronomy. He perfected a map projection that was the first to represent the spherical surface of the earth in two dimensions. The Mercator Projection effectively transformed navigation, making it possible for ships to deliver cargo safely to any port on the globe. Inspired by the spirit of our namesake, Mercator MedSystems has developed a medical technology that enables the safe and accurate delivery of therapies anywhere in the body, ranging from drugs for diseased blood vessels, to stem cells that regenerate ailing tissues and organs. We believe this breakthrough will allow the expansion of medical therapy and stimulate profound intellectual exploration into new treatments for disease. We invite you to explore our web site, our technology and products, and to follow our progress to a new world of therapeutic delivery.

Stealth BioTherapeutics, Inc., part of Stealth BioTherapeutics Corp., is a company headquartered in Newton, MA, that develops therapies to treat the mitochondrial dysfunctions and age-related diseases. The firm was founded in 2007. Irene P. McCarthy is the current CEO, occupying that position since 2009.\nThe company says this about itself: The Company is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. Dysfunctional mitochondria characterize a number of rare genetic diseases and are involved in many common age-related diseases, typically involving organ systems with high energy demands such as the eye, the neuromuscular system, the heart and the brain. The Company believes that its lead product candidate, elamipretide, has the potential to treat ophthalmic diseases, such as dry AMD, rare neuromuscular disorders, such as primary mitochondrial myopathy, and rare cardiomyopathies, such as Barth syndrome. The Company has a deep pipeline of novel mitochondria-targeted compounds under evaluation as therapeutic product candidates.

ReCor Medical has developed a unique therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The PARADISE® technology (Percutaneous Renal Denervation System) includes a 6 French catheter with a cylindrical transducer that emits ultrasound energy circumferentially, allowing for a more efficient renal denervation procedure.

HDL Therapeutics have developed the first therapy of its kind to rapidly reverse coronary atherosclerosis in patients with Homozygous Familial Hypercholesterolemia (HoFH).

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Part of Abbott Laboratories, St. Jude Medical, Cardiology Division, Inc. is a company headquartered in St. Paul, MN. The firm develops and commercializes minimally invasive cardiovascular and neurovascular medical devices. It was founded by Paul R. Buckman. Lisa D. Earnhardt is currently the CEO of the company.

APT Medical, Inc. engages in the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. Its electrophysiology products consist of electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters, and multi-channel electrophysiology systems. The company's coronary access products are composed of guide wires, microcatheters, balloons, and contrast guide wires and catheters. Its peripheral vascular intervention products include microcatheters, peripheral adjustable valve catheter sheath, contrast catheters, and contrast guide wires. The company also manages original equipment manufacturer business providing various types of vascular and non-vascular delivery systems, catheters, guide wires, and nickel-titanium products. APT Medical was founded by Zheng Hui Cheng on June 17, 2002 and is headquartered in Shenzhen, China.

Zhengzhou Meigang Hi-Tech Biotechnology Co., Ltd., established on 2018-11-12, Business scope includes biotechnology research and development;Ikind,Class II,Class III medical device,medicalXX-ray and magnetic resonance equipment,Medical nuclide equipment,Biological product,Medical polymer materials and products,Intervention equipment,implant material,software,Technical research and development of tissue engineering products,technical consulting,Technical Services,technology transfer;Health Management Consulting;Biomedical and medical information consultation;Sales:Instrumentation,biologics,Medical electronic equipment,medicine,Ikind,Class II,Class III medical device;Import and export of goods or technology.

Shanghai Shape Memory Alloy Co., Ltd. engages in the research and development, production, and marketing of occluders and vascular plugs. Its business activities include development of shape memory alloys, production of embolism equipment, and export and import business. The company was founded on May 5, 1994 and is headquartered in Shanghai, China.

Haixun Medical Technology (Suzhou) Co., Ltd, established on 2019-12-23, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Import and export;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hunan Apte Medical Equipment Co., Ltd., established on 2006-12-19, The scope of business includes Class II:03-13Neuro and Cardiovascular Surgical Instruments-Cardiovascular Interventional Devices;02-11Surgical Instruments-retractor;Class III:03-13-Neuro and Cardiovascular Surgical Instruments-Cardiovascular Interventional Devices(The medical device production license is valid until2022year9moon14day);6815injection puncture device,6821Medical electronic equipment,6822Medical Optics,Instruments and endoscopic equipment,6845Extracorporeal circulation and blood treatment equipment,6846Implantable materials and artificial organs,6854operating room,emergency room,Consulting room equipment and appliances,6866Medical polymer materials and products,6877Interventional Equipment Sales(The medical device business license is valid until2022year12moon12day);metallic material,plastic products,Wujinjiaodian,building materials(Free of silicone glue and wood),General Machinery;Engage in import and export of goods and technology with valid filing documents(Except for the import and export business prohibited or restricted by the state);Business Printing Service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)